JP Stock MarketDetailed Quotes

4552 JCR Pharmaceuticals

Watchlist
  • 660
  • -3-0.45%
20min DelayMarket Closed Sep 13 15:00 JST
85.59BMarket Cap15.03P/E (Static)

JCR Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JCR Pharmaceuticals Q1 2025 Earnings Date

Currency：JPYJul 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
11.30B
8.15B
-3.16B
Miss Est.
+4.55%
-24.64%
-27.92%
EPS
16.83
1.61
-15.22
Miss Est.
+30.34%
-87.47%
-90.43%
Analyst Rating
Buy

Sep 11, 2024

JCR Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 11.300B--
Oct 30, 20242025/Q2-- / 11.300B--
Jul 30, 20242025/Q18.145B / 11.300B--
May 10, 20242024/Q49.153B / 12.382B--
Jan 26, 20242024/Q39.446B / 13.000B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 11.300B--
Oct 30, 20242025/Q2-- / 11.300B--
Jul 30, 20242025/Q18.145B / 11.300B--
May 10, 20242024/Q49.153B / 12.382B--
Jan 26, 20242024/Q39.446B / 13.000B--

Unlock Free Earnings Estimates

JCR Pharmaceuticals Earnings Reports

  • JCR Pharmaceuticals: Earnings reports for Q1 of March 2025 will be announced in a conference call.

    Jul 30 03:00 ET

  • JCR Pharmaceuticals: 2025 March 1st quarter financial report announcement [Japan standard] (Consolidated)

    Jul 30 03:00 ET

  • JCR Pharmaceuticals: Extraordinary Report

    Jul 23 03:30 ET

  • JCR Pharmaceuticals: Interim report

    Jun 27 20:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 11, 2024

    Buy

    • Strong Buy

      28.57%

    • Buy

      0.00%

    • Hold

      71.43%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data